Razzaghi H, Martin DN, Quesnel-Crooks S, Hong Y, Gregg E, Andall-Brereton G, et al. 10-year trends in noncommunicable disease mortality in the Caribbean region. Rev Panam Salud Publica. 2019;43:e37.

PubMed  Google Scholar 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2021;71(3):209–49.

Frick C, Rumgay H, Vignat J, Ginsburg O, Nolte E, Bray F, et al. Quantitative estimates of preventable and treatable deaths from 36 cancers worldwide: a population-based study. Lancet Glob Health. 2023;11(11):e1700–12.

Article  CAS  PubMed  Google Scholar 

Neda I, Etemad K, Mohseni P, Khosravi A, Akbari M. Mortality rates and years of life lost due to cancer in Iran: analysis of data from the National Death Registration System, 2016. Int J Cancer Manage. 2022;15.

Liu M, An R, Wu Z, Dai L, Zeng Q, Chen W. The trajectory of oral mucositis in head and neck cancer patients undergoing radiotherapy and its influencing factors. Ear Nose Throat J. 2024;0(0):01455613241228211.

Article  Google Scholar 

Alshammari FD, Ahmed HG, Alshammari D, Alharbi AM, Alsaedi AS, Elasbaly A. Population insight of the relationship between lifestyle and cancer: a population-based survey. AIMS Public Health. 2019;6(1):34–48.

Article  PubMed  Google Scholar 

Fentie H, Ntenda PAM, Tiruneh FN. Dietary pattern and other factors of breast cancer among women: a case control study in Northwest Ethiopia. BMC Cancer. 2023;23(1):1050.

Article  PubMed  Google Scholar 

Debela DT, Muzazu SG, Heraro KD, Ndalama MT, Mesele BW, Haile DC, et al. New approaches and procedures for cancer treatment: current perspectives. SAGE Open Med. 2021;9:20503121211034366.

Article  PubMed  PubMed Central  Google Scholar 

Pucci C, Martinelli C, Ciofani G. Innovative approaches for cancer treatment: current perspectives and new challenges. Ecancermedicalscience. 2019;13:961.

Article  PubMed  Google Scholar 

He B, Sun H, Bao M, Li H, He J, Tian G, et al. A cross-cohort computational framework to trace tumor tissue-of-origin based on RNA sequencing. Sci Rep. 2023;13(1):15356.

Article  CAS  PubMed  Google Scholar 

He B, Zhang Y, Zhou Z, Wang B, Liang Y, Lang J, et al. A neural network framework for predicting the tissue-of-origin of 15 common cancer types based on RNA-Seq data. Front Bioeng Biotechnol. 2020;8:737.

Article  PubMed  Google Scholar 

Li M, Wei J, Xue C, Zhou X, Chen S, Zheng L, et al. Dissecting the roles and clinical potential of YY1 in the tumor microenvironment. Front Oncol. 2023;13:1122110.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Antony A, Joel J, Shetty J, Umar NF. Identification and analysis of adverse drug reactions associated with cancer chemotherapy in hospitalized patients. 2016;8:448–51.

van den Boogaard WM, Komninos DS, Vermeij WP. Chemotherapy side-effects: not all DNA damage is equal. Cancers. 2022;14(3):627.

Article  PubMed  Google Scholar 

Oun R, Moussa YE, Wheate NJ. The side effects of platinum-based chemotherapy drugs: a review for chemists. Dalton Trans. 2018;47(19):6645–53.

Article  CAS  PubMed  Google Scholar 

Fan Z, He Y, Sun W, Li Z, Ye C, Wang C. Clinical characteristics, diagnosis and management of sweet syndrome induced by azathioprine. Clin Experimental Med. 2023;23(7):3581–7.

Article  CAS  Google Scholar 

Hanigan MH, Devarajan P. Cisplatin nephrotoxicity: molecular mechanisms. Cancer Ther. 2003;1:47–61.

PubMed  Google Scholar 

Huizing MT, Misser VH, Pieters RC, ten Bokkel Huinink WW, Veenhof CH, Vermorken JB, et al. Taxanes: a new class of antitumor agents. Cancer Invest. 1995;13(4):381–404.

Article  CAS  PubMed  Google Scholar 

Hooker AC, Ten Tije AJ, Carducci MA, Weber J, Garrett-Mayer E, Gelderblom H, et al. Population pharmacokinetic model for docetaxel in patients with varying degrees of liver function: incorporating cytochrome P4503A activity measurements. Clin Pharmacol Ther. 2008;84(1):111–8.

Article  CAS  PubMed  Google Scholar 

Shirani K, Yousefsani BS, Shirani M, Karimi G. Protective effects of naringin against drugs and chemical toxins induced hepatotoxicity: a review. Phytother Res. 2020;34(8):1734–44.

Article  CAS  PubMed  Google Scholar 

Mohaghegh F, Solhi H, Kazemifar AM. Silymarin (milk thistle) can revoke liver enzyme changes during chemotherapy of breast cancer with Taxanes. Eur J Integr Med. 2015;7(6):650–2.

Article  Google Scholar 

Datta S, Aggarwal D, Sehrawat N, Yadav M, Sharma V, Sharma A, et al. Hepatoprotective effects of natural drugs: current trends, scope, relevance and future perspectives. Phytomedicine. 2023;121:155100.

Article  PubMed  Google Scholar 

Chaachouay N, Zidane L. Plant-derived natural products: a source for drug discovery and development. Drugs Drug Candidates. 2024;3(1):184–207.

Article  Google Scholar 

Desai AG, Qazi GN, Ganju RK, El-Tamer M, Singh J, Saxena AK, et al. Medicinal plants and cancer chemoprevention. Curr Drug Metab. 2008;9(7):581–91.

Article  CAS  PubMed  Google Scholar 

Gao T-H, Liao W, Lin L-T, Zhu Z-P, Lu M-G, Fu C-M, et al. Curcumae rhizoma and its major constituents against hepatobiliary disease: pharmacotherapeutic properties and potential clinical applications. Phytomedicine. 2022;102:154090.

Article  CAS  PubMed  Google Scholar 

Akbari B, Baghaei-Yazdi N, Bahmaie M, Mahdavi Abhari F. The role of plant‐derived natural antioxidants in reduction of oxidative stress. BioFactors. 2022;48(3):611–33.

Article  CAS  PubMed  Google Scholar 

Agrawal AD. Pharmacological activities of flavonoids: a review. Int J Pharm Sci Nanotechnology(IJPSN). 2011;4(2):1394–8.

Article  Google Scholar 

Pandey G, Sahni YP. A review on hepatoprotective activity of silymarin. Int J Res Ayurveda Pharm. 2011;2:75–9.

Google Scholar 

Newman DJ, Cragg GM. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J Nat Prod. 2020;83(3):770–803.

Article  CAS  PubMed  Google Scholar 

Jia R, Cao L, Du J, Xu P, Jeney G, Yin G. The protective effect of silymarin on the carbon tetrachloride (CCl4)-induced liver injury in common carp (Cyprinus carpio). Vitro Cell Dev Biol Anim. 2013;49(3):155–61.

Article  CAS  Google Scholar 

Shaker E, Mahmoud H, Mnaa S. Silymarin, the antioxidant component and Silybum marianum extracts prevent liver damage. Food Chem Toxicol. 2010;48(3):803–6.

Article  CAS  PubMed  Google Scholar 

Guo Y, Wang S, Wang Y, Zhu T. Silymarin improved diet-induced liver damage and insulin resistance by decreasing inflammation in mice. Pharm Biol. 2016;54(12):2995–3000.

Article  CAS  PubMed  Google Scholar 

Vrba J, Papoušková B, Kosina P, Lněničková K, Valentová K, Ulrichová J. Identification of human sulfotransferases active towards Silymarin flavonolignans and Taxifolin. Metabolites. 2020;10(8).

Loguercio C, Festi D. Silybin and the liver: from basic research to clinical practice. World J Gastroenterol. 2011;17(18):2288–301.

Article  CAS  PubMed  Google Scholar 

Bijak M. Silybin, a major bioactive component of milk thistle (Silybum marianum L. Gaernt.)—Chemistry, Bioavailability, and metabolism. Molecules. 2017;22(11):1942.

Article  PubMed  Google Scholar 

Anthony KP, Saleh MA. Free radical scavenging and antioxidant activities of Silymarin components. Antioxid (Basel). 2013;2(4):398–407.

Article  Google Scholar 

El-Lakkany NM, Hammam OA, El-Maadawy WH, Badawy AA, Ain-Shoka AA, Ebeid FA. Anti-inflammatory/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis. Parasites Vectors. 2012;5(1):9.

Article  CAS  PubMed  Google Scholar 

Induction of Microsomal Liver. Enzymes by silymarin in experimental animals. J Fac Med Baghdad. 2011;53(2):233–5.

Article